Keros Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $14,262 | $18,168 | $211,246 | $3,042 |
Gross Profit | 13,867 | 17,798 | 211,246 | 2,710 |
EBITDA | -8,309 | -32,548 | 152,384 | -29,142 |
EBIT | -8,704 | -32,918 | 152,040 | -29,474 |
Net Income | -7,280 | -30,696 | 148,451 | -46,026 |
Net Change In Cash | 14,262 | 18,168 | 211,246 | 3,042 |
Free Cash Flow | 3,117 | -30,343 | 160,606 | -46,297 |
Cash | 693,472 | 690,215 | 720,541 | 559,931 |
Basic Shares | 40,623 | 40,612 | 41,021 | 40,338 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $3,550 | $151 | $20,000 | $20,100 |
Gross Profit | 3,550 | 151 | -1,615 | 20,100 |
EBITDA | -185,824 | -152,177 | -104,004 | -56,351 |
EBIT | -187,053 | -152,992 | -104,678 | -56,729 |
Net Income | -187,353 | -152,992 | -104,679 | -58,744 |
Net Change In Cash | 3,550 | 151 | 20,000 | 20,100 |
Cost of Revenue | 49,006 | -34,622 | ||
Free Cash Flow | -162,800 | -126,972 | -71,303 | -63,172 |
Cash | 559,931 | 331,147 | 279,048 | 230,042 |
Basic Shares | 37,438 | 29,447 | 25,241 | 23,333 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.18 |
2025-06-30 | -$0.76 |
2025-03-31 | $3.62 |
2024-12-31 | -$1.14 |
